Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Bernstein

Showing results (111-120 of 379) with videos related to

Pageof 38
Sort By:
Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroidsWilliam E Berger, Edward Kerwin, David I Bernstein, et al.
Postgraduate Medicine|March 23, 2017
Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthmaStephen Brunton, Harold S Nelson, David I Bernstein, et al.
Sexually Transmitted Diseases|February 22, 2018
Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-ProtectionMónica Saccucci, Eduardo L Franco, Lili Ding, et al.
Antiviral Research|February 20, 2010
Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapyNicholas Farley, David I Bernstein, Fernando J Bravo, et al.
Pediatrics|December 15, 2010
Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 dosesLea E Widdice, David I Bernstein, Anthony C Leonard, et al.
Postgraduate Medicine|March 23, 2017
A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practiceDavid I Bernstein, Jose A Bardelas, Bodil Svanholm Fogh, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infectionFernando J Bravo, David I Bernstein, James R Beadle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot studyDavid I Bernstein, Spotswood L Spruance, Sujata S Arora, et al.
Human Vaccines & Immunotherapeutics|January 12, 2019
Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introductionCourtney Covert, Lili Ding, Darron Brown, et al.
Human Immunology|July 24, 2010
Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutininRamu A Subbramanian, Saleem Basha, Rebecca C Brady, et al.
Pageof 38

Showing results (111-120 of 379) with videos related to

Sort By:
Pageof 38
Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroidsWilliam E Berger, Edward Kerwin, David I Bernstein, et al.
Postgraduate Medicine|March 23, 2017
Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthmaStephen Brunton, Harold S Nelson, David I Bernstein, et al.
Sexually Transmitted Diseases|February 22, 2018
Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-ProtectionMónica Saccucci, Eduardo L Franco, Lili Ding, et al.
Antiviral Research|February 20, 2010
Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapyNicholas Farley, David I Bernstein, Fernando J Bravo, et al.
Pediatrics|December 15, 2010
Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 dosesLea E Widdice, David I Bernstein, Anthony C Leonard, et al.
Postgraduate Medicine|March 23, 2017
A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practiceDavid I Bernstein, Jose A Bardelas, Bodil Svanholm Fogh, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infectionFernando J Bravo, David I Bernstein, James R Beadle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot studyDavid I Bernstein, Spotswood L Spruance, Sujata S Arora, et al.
Human Vaccines & Immunotherapeutics|January 12, 2019
Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introductionCourtney Covert, Lili Ding, Darron Brown, et al.
Human Immunology|July 24, 2010
Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutininRamu A Subbramanian, Saleem Basha, Rebecca C Brady, et al.
Pageof 38